In the News

By Denise Baez

Cumulative exposure to cigarette smoke is an independent risk factor for hospital admission and death from coronavirus disease 2019 (COVID-19), according to a study published in JAMA Internal Medicine.

In a study of 7,102 patients who tested positive for...

By Denise Baez

A novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant has been identified in the United Kingdom, and preliminary analysis suggests that the variant is significantly more transmissible than previously circulating variants, according to a Threat...

The US Food and Drug Administration (FDA), on December 18, 2020, issued an emergency use authorisation (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

The EUA allows Moderna’s...

The American College of Allergy, Asthma, and Immunology (ACAAI) has issued guidance for physicians and other providers related to the risk of an allergic reaction following vaccination with an mRNA-based coronavirus disease 2019 (COVID-19) vaccine.

ACAAI’s recommendations are in line with...

By Denise Baez

Among patients with coronavirus disease 2019 (COVID-19) who were treated during the first 2 months of the pandemic in New York City, early tracheostomy was noninferior to late tracheostomy, and was associated with improvement in some outcomes, according to a study published...

By Denise Baez

NEW YORK -- December 17, 2020 -- Both hyperglycaemia and hypoglycaemia were associated with poor outcomes in patients with coronavirus disease 2019 (COVID-19), according to a study published in Diabetes Care.

An analysis of 1,544 patients with COVID-19 from 91...

By Denise Baez

NEW YORK -- December 17, 2020 -- The US Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) has voted in favour of issuing an Emergency Use Authorization (EUA) to Moderna’s mRNA-1273 coronavirus disease 2019 (COVID-19)...

The US Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the first over-the-counter (OTC) fully at-home diagnostic test for coronavirus disease 2019 (COVID-19).

The Ellume COVID-19 Home Test is a rapid, lateral flow antigen test that detects fragments of...

The US Food and Drug Administration (FDA) issued the first emergency use authorisation (EUA) for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals aged 16 years and older.

The EUA...

By Denise Baez

Baricitinib plus remdesivir was superior to remdesivir alone in reducing recovery time and accelerating improvement in clinical status among patients hospitalised with coronavirus disease 2019 (COVID-19), especially among ventilated patients, according to a study published...

Pages